New Delhi, May 22 -- Pune-headquartered pharma company Emcure Pharmaceuticals on Thursday reported that its Profit After Tax or net profit in the January-March 2025 quarter grew 63 per cent to Rs 197 crore.

In the same quarter of 2023-24, the pharma company's net profits were at Rs 121 crore.

The company's revenue from operations rose 19.5 per cent to Rs 2,116 crore. In the year ago period, the revenue mop up was at Rs 1,771 crore.

In the entire year 2024-25, the net profits rose 34.1 per cent to Rs 707 crore, and the revenue from operations rose 18.6 per cent to Rs 7,896 crore.

Emcure Pharmaceuticals on Thursday announced its consolidated financial results for the quarter and year ended March 31, 2025.

The quarter saw strong perform...